Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0T3JF
|
|||
| Former ID |
DNCL002095
|
|||
| Drug Name |
GliAtak
|
|||
| Synonyms |
GliAtak (TN)
Click to Show/Hide
|
|||
| Indication | Brain cancer [ICD-11: 2A00] | Phase 3 | [1] | |
| Prostate cancer [ICD-11: 2C82.0] | Phase 3 | [1] | ||
| Company |
Advantagene
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01436968) Phase 3 Study of ProstAtak Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.